The current standard of treatment for HIV/AIDS is the highly active antiretroviral therapy (HAART). This therapy typically consists of a triple
|
|
- Maurice Baldwin
- 6 years ago
- Views:
Transcription
1 1
2 2
3 3
4 4
5 The current standard of treatment for HIV/AIDS is the highly active antiretroviral therapy (HAART). This therapy typically consists of a triple cocktail of a nucleoside reverse transcriptase inhibitor (NRTI), a non nucleoside reverse transcriptase inhibitor (NNRTI) and a protease inhibitor (PI). Although these cocktails have been successful in greatly reducing mortality, viral loads and restoring immune function, they do not represent a cure, 5
6 It is estimated that an average patient would require anywhere from years to purge the latent memory T lymphocyte reservoir The latent T cell memory reservoir are T cells in the body capable of living for a long time. Hence, HIV that is not replicating, or latent, can exist for years undetected. 6
7 HIV infects million people worldwide (UNAIDS Report, 2005). It is predicted that in the absence of drastically expanded prevention and treatment efforts, at least 68 million people will die from AIDS between the years 2000 and In the United States of America (USA), it is estimated that over 900,000 people are infected with HIV (UNAIDS Report, 2003). It is estimated that HIV/AIDS causes approximately 3 million deaths annually worldwide, and 15,000 annually in the USA (UNAIDS Report, 2003). 7
8 Perhaps more urgent however, there are concerns regarding adverse effects associated with long term usage of HAART. Specifically, a variety of metabolic disorders including HIVassociated lipodystrophy 2, central adiposity 3, dyslipidaemia 4, hyperlipidaemia 5, hyperglycemia 6 and insulin resistance 7 have been reported as resulting from HAART (Vigouroux et al., 1999; Behrens et al., 2000; Powderly, 2002). 8
9 9
10 is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. 10
11 Central Adiposity can lead to Cardiovascular disease, Diabetes, sleep apnea and osteoarthritis 11
12 Mostly showing up as hyperlipidemia which can lead to cardiovascular disease, or acute pancreatitis 12
13 These reactions, which range between 1% and 30% of patients for each drug in a treatment regimen of three drugs, combined with complex and cumbersome dosing regimes, can have an adverse impact on patient compliance. 13
14 Considering the percentage of adverse events when taking three drugs together, it is evident that management of HIV infection with HAART is difficult for a large proportion of patients. 14
15 The law of similars states that a substance that causes symptoms similar to those of the disease, can also cure the disease. The originator of homeopathy, Samuel Hahnemann had his original epiphany with quinine and malaria. After taking a small dose of quinine, he began to have intermittent fever like symptoms, similar to Malaria. So he hypothesized that might be the reason quinine worked with malaria, because it caused similar symptoms a theory also postulated by Hippocrates much earlier. The basic assumption with homeopathy as well as many other holistic therapies is that the body mind has the resources necessary overcome many diseases. Homeopathy is applying the direction or acts as a catalyst to stimulate the system to overcome the problem. As long as we are relying on exogenous influences such as drugs to shore up or do the work the immune system should be doing, there will always be side effects, always be an immune system that is not up to it s full potential. In essence, conventional medicine is making the assumption that the body mind of the AIDS patient is incapable of mounting a defense so therapy is aimed at doing the defense work. But the truth is, we don t really know what the body mind is capable of unless we try therapies that are oriented towards strengthening the system such as homeopathy. 15
16 Samuel Hahnemann and his homeopathic colleagues had great success treating various epidemics that broke out in Europe. In addition, there are multiple records in town newspapers, homeopathic records and community registers all over the world from the early 1800 s through to the early 1900 s. Some are small isolated entries, while there are also larger records at various hospitals and health centers around the world. 16
17 There are thousands of records in town newspapers, homeopathic records and community registers all over the world from the early 1800 s through to the early 1900 s. Some are small isolated entries while some are records from hospitals, health centers and entire districts. 17
18 Here are some general statistics for a variety of infectious Diseases: 18
19 Here are some general statistics for a variety of infectious Diseases: 19
20 There was controversy when Dr. Bakody published his results. Accusations were made by his colleagues stating he was falsifying records. However he was exonerated when he brought records of the names and records for each of his records which was independently verified by the city health examiners. 20
21 You can also find multiple angry and dismissive entries in various town registers and news papers by allopathic physicians of the day. But the records of the claims by homeopaths have been verified. In several cases, given the superior results, communities lobbied to have homeopathic treatment be the exclusive treatment for the various diseases. In many cases, the homeopathic physicians had to turn away patients as they were overwhelmed with patients once they heard of the results. 21
22 22
23 The tiny number 6 is the only known survivors of Rabies as listed by the CDC. All the cases had serious sequelae and never fully recovered. Searching through homeopathic literature, Dr. Andre Saine found 12 cases that were fully recovered using homeopathic treatment alone fully recovered with no long term side effects. From Wikipedia: Rabies (Latin: rabies, "madness, rage, fury") is a viral zoonotic disease that causes acute encephalitis (inflammation of the brain) in mammals. In non vaccinated humans, rabies is almost invariably fatal after neurological symptoms have developed, but prompt post exposure vaccination may prevent the virus from progressing. There are only six known cases of a person surviving symptomatic rabies, and only one known case of survival in which the patient received no rabies specific treatment either before or after illness onset. [1] 23
24 Dr. Saine has been fastidiously compiling all the statistics and records from records all over the world and in multiple languages. So far he s found hundred of records to show how homeopathy was capable of treating and resolving these conditions with excellent success. He s reportedly working on publishing a book with references. 24
25 Of course, those days are gone. Many of those diseases don t exist in our modern world except in the third world. The opportunity to treat AIDS patients in current society by homeopathic treatment is minimal. Currently there is minimal data to support the idea that homeopathy can help in the treatment of AIDS. One Study: The study suggests a possible role of homeopathic treatment in HIV infection in symptomatic phase, as evidenced by a statisticallysignificant significant elevation of base line immune status in persistent generalised lymphadenopathy.. The only we will be able to know if homeopathy is effective with AIDS is if we treat enough patients to get the data. 25
26 Back in the 1900 s despite the success that homeopathy had with so many serious diseases, it was largely ignored and forgotten. Only if we reverse that trend of ignoring what seems impossible, will we discover new ways to help AIDS patients. If we don t begin to work outside the box, we ll mostly end up with the same results controlling the immune system with drugs, rather than encouraging the body and mind to begin the process of self healing. Of course, it is possible that homeopathy can t help with AIDS enough to merit it s use, but we won t know unless we try. Certainly it s past history suggests thatitmaybe useful. 26
27 I traveled to Kenya in 2000 to help to open an AIDS clinic in a slum of Nairobi called kariobungi. I treated very severe cases, patients that had no funds and were severly ill patients who would be at the ER in industrialized countries. I saw immediate and profound improvements with patients while there. There are a handful of cases and my experiences of that clinic listed on my website. 27
28 If enough patients can be treated with homeopathy and we can publish the outcomes, we can begin to have the data to find out if Homeopathy can make a difference with these patients. I would welcome any referrals and collaboration with regards to treatment and collecting good cases. 28
29 29
30 30
Written by Arlan Cage, ND, Lac Thursday, 01 March :00 - Last Updated Thursday, 26 February :39
Informed Consent The principle of Informed Consent has its roots in millenniaold medical ethics, and in modern times has become codified as law. Federal regulations require that doctors tell patients in
More informationcure research HIV & AIDS
Glossary of terms HIV & AIDS cure research Antiretroviral Therapy (ART) ART involves the use of several (usually a cocktail of three or more) antiretroviral drugs to halt HIV replication. ART drugs may
More informationHIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.
HIV Drug Resistance Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Resistance? HIV drugs are designed to keep the amount of HIV virus
More informationHow HIV Works in Your Body
How HIV Works in Your Body It helps to know what s going on with your virus What is HIV and how do people get it? The initials HIV stand for Human Immunodeficiency Virus meaning a virus that causes the
More informationCHAPTER - IV OBJECTIVES OF THE STUDY
CHAPTER - IV OBJECTIVES OF THE STUDY 4.1 BACKGROUND Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) commonly referred to as HIV & AIDS have emerged as being
More informationDiagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know
Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013
More informationMaking decisions about therapy
JANUARY 2011 Making decisions about therapy Making decisions about treating your HIV may feel overwhelming. Developing a plan that helps you think about, plan for and make treatment decisions can help.
More informationProgress against the HIV Epidemic: is the end in sight?
Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern
More informationPart 2 of our 3 part series! Making MEDS Work for You
Part 2 of our 3 part series! 2 Making MEDS Work for You Table of Contents 3 Introduction 4 Is there a cure for HIV/AIDS? How HIV medications keep HIV from making copies 5 How do antiretrovirals work? 6
More informationA VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART
BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)
More informationCh 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems
Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Highlight Disease: Malaria World s dominant protozoal disease. Four species of Plasmodium: P. falciparum (malignant), P. vivax (begnin),
More informationThe Struggle with Infectious Disease. Lecture 6
The Struggle with Infectious Disease Lecture 6 HIV/AIDS It is generally believed that: Human Immunodeficiency Virus --------- causes ------------- Acquired Immunodeficiency Syndrome History of HIV HIV
More informationIs Tesamorelin a Safe and Effective Drug to Treat Lipodystrophy in HIV Patients?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2012 Is Tesamorelin a Safe and Effective Drug
More information5. How visual representation in both the arts and sciences is critical for advancing important ideas about HIV/AIDS.
Welcome to Week 5 Ø Please watch the online video (51 seconds). Over the past four weeks, you have learned: 1. How to do a basic analysis of literary and scientific texts. 2. How scientists and artists
More informationPandemic Preparedness: Pigs, Poultry, and People versus Plans, Products, and Practice
SUPPLEMENT ARTICLE Pandemic Preparedness: Pigs, Poultry, and People versus Plans, Products, and Practice Julie L. Gerberding Centers for Disease Control and Prevention, Atlanta, Georgia Influenza pandemic
More informationHIV depletes T-helper17, we simply stimulate it. By Prof. Dr.Pichaet Wiriyachitra Ph.D., F.R.A.C.I.
HIV depletes T-helper17, we simply stimulate it By Prof. Dr.Pichaet Wiriyachitra Ph.D., F.R.A.C.I. Natural Healthcare for HIV infected HIV depletes T-helper17, we simply stimulate it Dr.Pichaet Wiriyachitra
More informationHIV and Common Comorbidities August 17, Michael MacVeigh, MD & Kristen Meyers, BS, CADC1
HIV and Common Comorbidities August 17, 2017 Michael MacVeigh, MD & Kristen Meyers, BS, CADC1 Learning Objectives 1) Confidently discuss basics of ARVs and common side effects of these medications 2) Understand
More informationACT UP (AIDS Coalition To Unleash Power): HIV/AIDS activist group founded in 1987 in New York City.
GLOSSARY OF TERMS ACT UP (AIDS Coalition To Unleash Power): HIV/AIDS activist group founded in 1987 in New York City. Agitprop: a term used to describe political art meant to agitate and spread propaganda.
More informationClassical Homeopathy 1/1/2016. Dr. Julia Parke, ND Pure Naturopathic Medicine JULIAPARKE.COM. Copyright 2016 Dr. Julia Parke, ND. JuliaParke.
1/1/2016 Classical Homeopathy Dr. Julia Parke, ND Pure Naturopathic Medicine JULIAPARKE.COM Classical Homeopathy History of Homeopathy Homeopathy is a highly systematic, scientific method of therapy based
More informationHomeopathy Informed Consent
www.enlivenmbs.com info@enlivenmbs.com (347) 470-0766 Fax: (888)447-1261 11000 N. Scottsdale Road, Scottsdale, AZ 85254 Homeopathy Informed Consent What is homeopathy? Homeopathy is a safe and effective
More informationCOMPLEMENTARY APPROACHES TO HIV AIDS TREATMENT
COMPLEMENTARY APPROACHES TO HIV AIDS TREATMENT By Peter de Ruyter 2 Complementary Approaches To HIV AIDS Treatment Copyright Peter de Ruyter-2012-All Rights Reserved Permission is hereby granted to freely
More informationEarly Antiretroviral Therapy
Early Antiretroviral Therapy HIV Cure Research Training Curriculum HIV and Cure Early ART Presented by: Jintanat Ananworanich, MD, PhD June 2016 The HIV CURE research training curriculum is a collaborative
More informationUNRAVELING THE MYSTERY BEHIND HIV/AIDS
PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise
More informationPneumococcal Vaccines: Questions and Answers
Pneumococcal Vaccines: Questions and s Question 1 What is pneumococcal disease? What is pneumococcal disease? So pneumococcal disease is a group of diseases that are caused by a bacteria. Most of us are
More informationThe Global State of HIV/AIDS. Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill
The Global State of HIV/AIDS Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill siobhany@email.unc.edu Outline HIV/AIDS 101 Origin of AIDS State of the Epidemic HIV/AIDS in Sub-Saharan
More informationToolkit Instructions. Read and complete the 5 assignments in this toolkit.
Keep it Safe Toolkit Toolkit Instructions Read and complete the 5 assignments in this toolkit. N. G. Bartholomew, D. F. Dansereau, K. Knight, and D. D. Simpson TCU Institute of Behavioral Research Welcome
More information8/10/2017. HIV UPDATE 2017 David M Stein DO, FACOI
HIV UPDATE 2017 David M Stein DO, FACOI 1 Current US HIV data 1.1 million HIV positive 1 out of 7 positive are unaware of their status Highest risk in Gay and Bisexual men, young African American men 2
More informationOn behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in
Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education
More information1. E-learning: NHIVNA HIV modules on the NHIVNA website
Vers Jan 18 E LEARNING sessions to complete for STIF NHIVNA Core Competency 1. E-learning: NHIVNA HIV modules on the NHIVNA website http://www.nhivna.org/nhivna-hiv-nursing-modules.aspx The NHIVNA HIV
More informationChapter 08 Lecture Outline
Chapter 08 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. Permission required for reproduction
More informationTHE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work
THE HIV LIFE CYCLE Understanding How Antiretroviral Medications Work DEFINITIONS Host: The animal or cell that another organism lives in. In HIV human CD4 T-cells are the host for HIV. Nucleus: The core
More informationTreatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)
Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV) Amantadine and Rimantadine Use is limited to Influenza A infection. Very effective in preventing infection if
More informationWhat You Need to Know About. TB Infection TUBERCULOSIS
What You Need to Know About TB Infection TUBERCULOSIS What s Inside: Take steps to make sure TB infection does not turn into TB disease. Read this booklet to learn how you can take control of your health.
More informationHIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body
HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University
More information2. According to the information provided by the WHO, there is no justification at this stage for restrictions on travel or trade.
Outbreak of Plague in Madagascar The following information is being disseminated by both the International Chamber of Shipping and The International Transport Workers Federation to draw attention to the
More informationHow has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH
How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS
More informationManagement of Antiretroviral Treatment (ART) and Long-Term Adherence to ART
Thailand s Annual International Training Course (AITC) 2017 Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART I. Proposal Title: Management of Antiretroviral Treatment (ART) and
More informationModeling Measles Vaccination in Texas
Modeling Measles Vaccination in Texas The Importance of Community (Herd) Immunity Mark S. Roberts, MD, MPP Professor and Chair, Department of Health Policy and Management Professor of Medicine, Industrial
More informationDay One: After you ve tested positive
JANUARY 2011 Day One: After you ve tested positive A positive HIV antibody test is scary news, but you have time to consider the many aspects to this new development in your life. As we learn more about
More informationThe Current Status of the Epidemiologic Transition
The Current Status of the Epidemiologic Transition There are still job opportunities in Infectious Diseases and Tropical Medicine CAPT John W. Sanders, Medical Corps, US Navy Commanding Officer, Naval
More informationLESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV
LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent
More informationCreate the Following Chart in your notebook. Fill in as you go through each one.
Diseases of Africa Create the Following Chart in your notebook. Fill in as you go through each one. History of disease? Affected Population? How do you catch the disease? Symptoms? Prevention / Treatment?
More informationImproving accessibility to antiretroviral drugs: A south-south collaboration
Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000
More informationMedia centre Global infectious disease surveillance
Media centre Global infectious disease surveillance Fact sheet N 200 Increased movements of people, expansion of international trade in foodstuffs and medicinal biological products, social and environmental
More information0% 0% 0% Parasite. 2. RNA-virus. RNA-virus
HIV/AIDS and Treatment Manado, Indonesia 16 november HIV [e] EDUCATION HIV is a 1. DNA-virus 2. RNA-virus 3. Parasite 0% 0% 0% DNA-virus RNA-virus Parasite HIV HIV is a RNA-virus. HIV is an RNA virus which
More informationCritical Mass Analysis
Critical Mass Analysis Greetings Welcome to this presentation entitled Critical Mass Analysis. I d like to introduce you to, or perhaps even more so, orient you to, the concept I m approaching in this
More informationObjectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.
1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships
More informationMeridian Stress Assessment
Meridian Stress Assessment Are You Experiencing Any of These?! Allergies! Digestive problems! Fatigue! Fibromyalgia! Foul breath! Frequent illness! Headaches! Irritability! Joint pains! Mental confusion
More informationHIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy
HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati
More informationModule 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
More informationBRIEF HISTORY WHY IK TANGA AIDS WORKING GROUP TANGA AIDS WORKING GROUP
TANGA AIDS WORKING GROUP TAWG INDIGENOUS KNOWLEDGE MANAGEMENT OF HIV/AIDS CASES PRESENTED AT THE VIDEO CONFERENCE ON THE ROLE OF INDIGENOUS KNOWLEDGE IN THE MANAGEMENT OF AIDS CASES AT THE DISTANT LEARNING
More informationThe Swarm: Causes and consequences of HIV quasispecies diversity
The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability
More informationAssessment of the therapeutic success of antiretroviral combinations used in a HIV treatment center, Jos, Nigeria
World Journal of Pharmaceutical Sciences ISSN (Print): 3-330; ISSN (Online): 3-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original Article
More informationPROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
More informationSummary of the risk management plan (RMP) for Rezolsta (darunavir / cobicistat)
EMA/608280/2014 Summary of the risk management plan (RMP) for Rezolsta (darunavir / cobicistat) This is a summary of the risk management plan (RMP) for Rezolsta, which details the measures to be taken
More information1592U89 (Abacavir) Resistance and Phenotypic Resistance Testing
1592U89 (Abacavir) Resistance and Phenotypic Resistance Testing Reported by Jules Levin, Executive Director of NATAP (3 March 1998) The following report contains a comprehensive update of the latest information
More informationTOXICITY, TOLERABILITY, AND ADHERENCE TO THERAPY
SAFETY AND TOLERABILITY OF CURRENTLY AVAILABLE ANTIRETROVIRAL AGENTS * Esteban Martinez, MD, PhD ABSTRACT Safety and tolerability are important factors to consider when instituting or modifying therapy
More informationMathematical Modeling of Infectious Diseases
Mathematical Modeling of Infectious Diseases Breakthrough Cincinnati s Super Saturday November 22, 2014 David J. Gerberry Assistant Professor of Mathematics Xavier University www.cs.xavier.edu/~david.gerberry!
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationStarting HIV Treatment
Starting HIV Treatment August 21, 2018 Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime#thewellproject First Things First When you and your health care provider
More informationComparison of Drug Treatment Protocols for Children Infected with HIV in Washington, DC and Cape Town, South Africa in Relation to NIH Guidelines
Comparison of Drug Treatment Protocols for Children Infected with HIV in Washington, DC and Cape Town, South Africa in Relation to NIH Guidelines Mariah M. Marshall Department of Human Science Georgetown
More informationHIV and Long Term Disability
HIV and Long Term Disability Minnesota AIDS Project The Minnesota AIDS Project envisions a world free of AIDS. Our mission is to lead Minnesota's fight to stop HIV through advocacy, education, and service.
More informationHS161 MIDTERM 3/24/04
HS161 MIDTERM 3/24/04 Instructions. Select the best response in each instance. For T/F questions, answer a for true and b for false. On Part A, please use a TE2000 scantron to record your answers. Use
More informationBiomedical Engineering for Global Health. Lecture 10 HIV/AIDS vaccine development
Biomedical Engineering for Global Health Lecture 10 HIV/AIDS vaccine development Review of lecture 9 How do vaccines work? Types ofvaccines: Review of lecture 9 Are vaccines effective? -Edward Jenner s
More informationHepatitis C Cure The Invisible Epidemic
Hepatitis C Cure The Invisible Epidemic Iris House 8 Th Annual Face of AIDS Summit Hadiyah Charles Hepatitis Advocacy Manager Harm Reduction Coalition Hepatitis C Basics A virus that can cause chronic
More informationAbout Veterinary Naturopathy
About Veterinary Naturopathy Principles of Veterinary Naturopathy Veterinary Naturopathy is based on six principles The Healing Power of Nature (vix medicatrix naturae) The body has the inherent ability
More informationMortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013
John F. White III, MD, MBA, FLMI VP and Medical Director American National Insurance Company 1 Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 2 1 3 My Opinions
More informationSeble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University
Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationHIV and YOU. Special 2008 Update!
HIV and YOU Special 2008 Update! HIV and You Special 2008 Update! In this booklet, you ll see words in bold, red type. Go to the Glossary on the back cover to find out what these words mean. WRITERS AND
More informationUnit 4 Student Guided Notes
Structure of Viruses Discovery of the Virus Unit 4 Student Guided Notes Many human epidemics were well documented and observed in history, but. The following 3 discoveries shaped our knowledge of viruses
More informationGlobal and National trends of HIV/AIDS
Research and Review Insights Research Article ISSN: 2515-2637 Global and National trends of HIV/AIDS Hikmat Bahadur Raya* Lecturer, Department of Population Studies, Tribhuvan University, Terhathum M.
More informationAP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size
Hepatitis Viral diseases Polio Chapter 18. Measles Viral Genetics Influenza: 1918 epidemic 30-40 million deaths world-wide Chicken pox Smallpox Eradicated in 1976 vaccinations ceased in 1980 at risk population?
More informationNatural history of HIV Infection
HIV in Primary Care Joint RCGP/BHIVA Multidisciplinary Conference Dr Ian Williams University College London Medical School Friday 25 January 2013, Royal College of General Practitioners, London HIV Treatment
More informationUp to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).
HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and
More informationCE Unit. Viruses and Vaccines
CE Unit Viruses and Vaccines DO NOT WRITE What is a virus? Have you ever had a virus? What is a vaccine? How is a virus different from bacteria? What are the deadliest viruses? 10. Dengue fever 50 million
More informationThe Future of HIV: Advances in Drugs and Research. Shauna Gunaratne December 17, 2018
The Future of HIV: Advances in Drugs and Research Shauna Gunaratne December 17, 2018 Overview Epidemiology Science of HIV How HIV treatment and management have changed over the years New medicines and
More informationNon-profit education, research and support network offers money in exchange for missing science
Alive & Well $50,000 Fact Finder Award Find One Study, Save Countless Lives Non-profit education, research and support network offers money in exchange for missing science http://www.aliveandwell.org Tel
More informationPrinciples of Antiretroviral Therapy
Principles of Antiretroviral Therapy Ten Principles of Antiretroviral Therapy Skills Building Workshop: Clinical Management of HIV Infection and Antiretroviral Therapy, 11 th ICAAP, November 21st, 2011,
More informationGood Health & Well-Being. By Alexandra Russo
Good Health & Well-Being By Alexandra Russo SDG 3 Goal 3 aims to ensure healthy living and promote well-being for all at all ages There are 9 targets associated with SDG 3 The targets encompass a wide
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Isolated in 1983 by Luc Montagnier & Robert Gallo, separately. Genetic material is RNA Carries reverse transcriptase, an enzyme that makes DNA out of RNA in the host cell Cells
More information, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic
1 Two attributes make AIDS unique among infectious diseases: it is uniformly fatal, and most of its devastating symptoms are not due to the causative agent Male to Male sex is the highest risk group in
More informationSession 1 Basic HIV Facts. Patient Navigation Intervention
Session 1 Basic HIV Facts Patient Navigation Intervention Session 1 HIV, the Viral Life Cycle & Understanding the Importance of HAART and Adherence https://www.aids.gov/hiv aids basics/just diagnosed with
More informationHIV Clinical Nurse Specialist CCDHB Wellington
RN James Rice-Davies HIV Clinical Nurse Specialist CCDHB Wellington 11:00-11:55 WS #88: Undiagnosed HIV in Your Practice 12:05-13:00 WS #99: Undiagnosed HIV in Your Practice (Repeated) HIV- Undiagnosed
More informationHealth advice for travelers
Health advice for travelers Welcome to Thailand Every year millions of tourists set Thailand as one of their favorite destinations. The information provided here will help you come up with appropriate
More informationHIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense
Micro 320: Infectious Disease & Defense HIV/AIDS & Immune Evasion Strategies Wilmore Webley Dept. of Microbiology The Year 1981 Reported by MS Gottlieb, MD, HM Schanker, MD, PT Fan, MD, A Saxon, MD, JD
More informationLECTURE topics: 1. Immunology. 2. Emerging Pathogens
LECTURE 23 2 topics: 1. Immunology 2. Emerging Pathogens Benefits of the Normal Flora: 1. Protect us from colonization by other bacteria and fungi (competitive exclusion). 2. Many synthesize vitamins,
More informationCLINICIAN INTERVIEW PHARMACY MANAGEMENT OF HIV AND OPPORTUNISTIC INFECTIONS IN A HOSPITAL SETTING. Interview with Christopher Miller, PharmD, BCPS
PHARMACY MANAGEMENT OF HIV AND OPPORTUNISTIC INFECTIONS IN A HOSPITAL SETTING Interview with Christopher Miller, PharmD, BCPS Dr Miller is currently employed in a joint position as an assistant professor
More informationHIV Management in Russia
HIV Management in Russia Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients By The Global Virology Therapy Monitor Team, Ipsos Healthcare
More information1980 Eradication Ended Vaccinations
Smallpox Basics The Politics of Smallpox Modeling Rice University - November 2004 Edward P. Richards, JD, MPH Director, Program in Law, Science, and Public Health Harvey A. Peltier Professor of Law Louisiana
More informationDNA Genotyping in HIV Infection
Frontier AIDS Education and Training Center DNA Genotyping in HIV Infection Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS Clinical Program; Professor of Medicine, Division of Infectious
More informationHIV Transmission HASPI Medical Biology Lab 20
HIV Transmission HASPI Medical Biology Lab 20 Background History of HIV/AIDS Acquired Immune Deficiency Syndrome (AIDS) was first seen in 1981 when large numbers of people with two rare diseases surfaced:
More informationNutrition Management Of HIV And AIDS By Ada READ ONLINE
Nutrition Management Of HIV And AIDS By Ada READ ONLINE If you are searched for a book Nutrition Management of HIV and AIDS by Ada in pdf form, then you have come on to loyal site. We present complete
More informationCOSTA RICA KEY. Public health is the study of how diseases spread in a population and the measures used to control them.
COSTA RICA KEY Controlling the Pandemic: Public Health Focus Just 25 years since it was first reported, HIV/AIDS has become one of the world s greatest public health crises. More than 39 million people
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationC h a p t e r 5 5 HIV Therapy Where are We Now?
C h a p t e r 5 5 HIV Therapy Where are We Now? AK Tripathi Professor of Medicine, Physician & Haemato-Oncologist, King George s Medical College, Lucknow Introduction Human Immunodeficiency Virus type
More informationWhy are the targets a game-changer? What is the Fast-Track Cities Initiative and its connection to ?
Frequently Asked Questions about 90-90-90 Targets, the HIV Care Continuum, the Updated National HIV AIDS Strategy (NHAS), and the Fast-Track Cities Initiative What is the origin of the 90-90-90 targets?
More information12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 20+ Exhibitors. Control and Prevention of HIV/AIDS, STDs & STIs. 50+ Plenary Lectures
6 th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs conferenceseries.com October 29-30, 2018 Valencia, Spain Dear Attendees, Invitation We are glad to announce the 6 th World Congress
More information